Patolawala Monish D 4

What Happened

• Monish D. Patolawala, a director of Biogen Inc. (BIIB), received an award of 1,505 restricted stock units (RSUs) on June 9, 2026. The filing reports the acquisition as 1,505 shares at $0.00 per share (total $0), reflecting a grant rather than a cash purchase or sale. This is an equity award that will convert to shares if and when the RSUs vest.

Key Details

• Transaction date: 2026-06-09; Form 4 filed: 2026-06-11 (appears timely — Form 4 is generally due within two business days).
• Transaction type/code: Award/Grant (A).
• Amount acquired: 1,505 RSUs at $0.00 per share (total reported $0).
• Shares owned after transaction: not specified in the provided filing details.
• Footnote: RSUs vest on the earlier of (i) the next annual meeting or (ii) the one-year anniversary of the grant date (June 9, 2026).
• No indication in the provided data of a 10b5-1 plan, tax withholding, or immediate sale.

Context

• This is a grant of restricted stock units — not an open-market purchase or sale. RSUs typically convert to common shares when vesting conditions are met; until then they do not represent immediately tradable shares.
• Grants to directors are common as part of compensation and do not, by themselves, indicate buy/sell timing or insider sentiment.